Lipid nanoparticles as drug delivery systems for apomorphine
碩士 === 長庚大學 === 中醫學系天然藥物 === 98 === Apomorphine is a dopamine receptor agonist for treating Parkinson’s disease. However, its inherent instability, negligible oral bioavailability, and short half-life (~41 min) have complicated its applicability in clinical practice. Apomorphine was used as a mo...
Main Authors: | Hui Wen Chang, 張惠雯 |
---|---|
Other Authors: | J. Y. Fang |
Format: | Others |
Published: |
2010
|
Online Access: | http://ndltd.ncl.edu.tw/handle/79346234186044962319 |
Similar Items
-
Development of the solid lipid nanoparticle formulation of apomorphine for oral delivery
by: Yao-Jen Kao, et al.
Published: (2008) -
Development and evaluation of drug delivery systems for apomorphine and its prodrugs
by: Ming Chuan Ku, et al.
Published: (2011) -
Study of apomorphine-loaded microemulsions for transdermal drug delivery
by: Yi-Cheng Chen, et al.
Published: (2014) -
Challenges and trends in apomorphine drug delivery systems for the treatment of Parkinson's disease
by: Nrupa Borkar, et al.
Published: (2018-11-01) -
controlled apomorphine delivery system based on thermosensitive biodegradable hydrogel
by: Yi-Xiu Chen, et al.
Published: (2005)